185750 Stock Chart & Stats
$66900.00
-$300.00(-0.45%)
―
--
Day’s Range― - ―
52-Week Range$63,000.00 - $98,100.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
₩885.43B
Enterprise Value$1.26M
Total Cash (Recent Filing)₩285.23B
Total Debt (Recent Filing)₩368.00B
Price to Earnings (P/E)11.2
Beta0.21
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,802,780
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-0.50
Price to Book (P/B)1.09
Price to Sales (P/S)0.65
P/FCF Ratio-14.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
185750 FAQ
What was Chong Kun Dang Pharmaceutical Corp.’s price range in the past 12 months?
Chong Kun Dang Pharmaceutical Corp. lowest stock price was $63000.00 and its highest was $98100.00 in the past 12 months.
What is Chong Kun Dang Pharmaceutical Corp.’s market cap?
Chong Kun Dang Pharmaceutical Corp.’s market cap is ₩885.43B.
When is Chong Kun Dang Pharmaceutical Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Chong Kun Dang Pharmaceutical Corp.’s earnings last quarter?
Currently, no data Available
Is Chong Kun Dang Pharmaceutical Corp. overvalued?
According to Wall Street analysts Chong Kun Dang Pharmaceutical Corp.’s price is currently Undervalued.
Does Chong Kun Dang Pharmaceutical Corp. pay dividends?
Chong Kun Dang Pharmaceutical Corp. does not currently pay dividends.
What is Chong Kun Dang Pharmaceutical Corp.’s EPS estimate?
Chong Kun Dang Pharmaceutical Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chong Kun Dang Pharmaceutical Corp. have?
Chong Kun Dang Pharmaceutical Corp. has 13,802,780 shares outstanding.
What happened to Chong Kun Dang Pharmaceutical Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Chong Kun Dang Pharmaceutical Corp.?
Currently, no hedge funds are holding shares in KR:185750
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Chong Kun Dang Pharmaceutical Corp.
Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. Its products include medicine for antidiabetics, antiviruses, beta-blockers, anti-hyperlipidemia, and others. The company was founded on May 7, 1941 and is headquartered in Seoul, South Korea.
JW Pharmaceutical Corporation
―
Daewoong Co., Ltd.
―
Boryung Corporation
―
GC Biopharma Corp.
―
DongKook Pharmaceutical Co., Ltd.
―